Nicolas André Selected Research

Mesothelioma

11/2020	Mesothelioma in children and adolescents: the European Cooperative Study Group for Pediatric Rare Tumors (EXPeRT) contribution.
7/2017	Mathematical modeling for Phase I cancer trials: A study of metronomic vinorelbine for advanced non-small cell lung cancer (NSCLC) and mesothelioma patients.
11/2006	Efficacy of a combination of pemetrexed and multiple redo-surgery in an 11-year-old girl with a recurrent multifocal abdominal mesothelioma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nicolas André Research Topics

Disease

61	Neoplasms (Cancer) 10/2022 - 05/2002
6	Medulloblastoma 08/2022 - 01/2018
6	Glioma (Gliomas) 01/2022 - 08/2015
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2021 - 09/2010
6	Neoplasm Metastasis (Metastasis) 01/2021 - 09/2007
5	Neuroblastoma 01/2021 - 12/2002
5	Rhabdomyosarcoma 10/2020 - 10/2012
5	Neutropenia 07/2020 - 11/2006
4	Breast Neoplasms (Breast Cancer) 01/2017 - 10/2011
3	Mesothelioma 11/2020 - 11/2006
3	Cardiotoxicity 06/2020 - 12/2016
3	Febrile Neutropenia 10/2016 - 03/2007
3	Hemangiosarcoma (Angiosarcoma) 04/2016 - 01/2014
2	COVID-19 12/2020 - 11/2020
2	Hematologic Neoplasms (Hematological Malignancy) 11/2020 - 10/2016
2	Malignant Mesothelioma 11/2020 - 04/2016
2	Thrombocytopenia (Thrombopenia) 07/2020 - 11/2006
2	Brain Neoplasms (Brain Tumor) 01/2018 - 07/2012
2	Triple Negative Breast Neoplasms 01/2017 - 10/2011
2	Lung Neoplasms (Lung Cancer) 01/2017 - 09/2014
2	Body Weight (Weight, Body) 10/2016 - 03/2007
2	Burkitt Lymphoma (Burkitt's Lymphoma) 10/2014 - 01/2011
2	Prostatic Neoplasms (Prostate Cancer) 01/2014 - 02/2009
2	Lymphoma (Lymphomas) 03/2012 - 05/2002
2	Ewing Sarcoma (Sarcoma, Ewing) 08/2009 - 01/2009
1	Brain Stem Neoplasms (Brain Stem Tumor) 01/2021
1	Diffuse Intrinsic Pontine Glioma 01/2021
1	Lymphopenia (Lymphocytopenia) 01/2021
1	Hypoxia (Hypoxemia) 10/2020
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2020
1	Hamartoma 01/2020
1	Ependymoma 01/2018
1	Neurofibroma 01/2018
1	Primitive Neuroectodermal Tumors (PNET) 01/2018
1	Typical Teratoid Rhabdoid Tumor 01/2017

Drug/Important Bio-Agent (IBA)

13	Pharmaceutical PreparationsIBA 08/2022 - 03/2010
7	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021 - 07/2008
6	Vinorelbine (Navelbine)FDA LinkGeneric 01/2022 - 10/2012
6	Bevacizumab (Avastin)FDA Link 01/2021 - 12/2010
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2011
4	Vinblastine (Vinblastine Sulfate)FDA Link 01/2021 - 02/2011
4	Irinotecan (Camptosar)FDA LinkGeneric 01/2021 - 07/2012
4	Gemcitabine FDA Link 01/2017 - 05/2010
3	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2020 - 12/2016
3	Propranolol (Inderal)FDA LinkGeneric 01/2017 - 10/2011
3	Cytarabine (Cytosar-U)FDA LinkGeneric 10/2014 - 08/2009
3	Antineoplastic Agents (Antineoplastics)IBA 11/2013 - 09/2007
3	Paclitaxel (Taxol)FDA LinkGeneric 10/2011 - 05/2002
2	Cell-Free Nucleic AcidsIBA 10/2022 - 01/2022
2	Adrenergic Receptors (Adrenergic Receptor)IBA 08/2022 - 04/2016
2	Phosphotransferases (Kinase)IBA 01/2022 - 01/2017
2	Sirolimus (Rapamycin)FDA Link 11/2021 - 10/2020
2	Pemetrexed (MTA)FDA Link 11/2020 - 11/2006
2	CateninsIBA 11/2020 - 08/2012
2	Vincristine (Oncovin)FDA LinkGeneric 07/2020 - 01/2011
2	AnthracyclinesIBA 06/2020 - 08/2015
2	Etoposide (VP 16)FDA LinkGeneric 01/2020 - 07/2008
2	Methotrexate (Mexate)FDA LinkGeneric 04/2016 - 01/2011
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2015 - 07/2012
2	Celecoxib (Celebrex)FDA Link 05/2013 - 07/2008
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2009 - 03/2007
2	Filgrastim (Neupogen)FDA Link 01/2009 - 03/2007
2	pegfilgrastim (Neulasta)FDA Link 01/2009 - 03/2007
1	Superoxides (Superoxide)IBA 08/2022
1	beta Adrenergic ReceptorsIBA 08/2022
1	Temozolomide (Temodar)FDA LinkGeneric 11/2021
1	vistusertibIBA 11/2021
1	Mechanistic Target of Rapamycin Complex 1IBA 11/2021
1	Topotecan (Hycamtin)FDA LinkGeneric 11/2021
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 11/2021
1	NivolumabIBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	BNT162 VaccineIBA 01/2021
1	COVID-19 VaccinesIBA 01/2021
1	dipinacoline glutamateIBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	3-Iodobenzylguanidine (Iobenguane)IBA 01/2021
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2021
1	TIC10 compoundIBA 01/2021
1	AsbestosIBA 11/2020
1	Dactinomycin (Actinomycin)FDA LinkGeneric 07/2020
1	Ifosfamide FDA LinkGeneric 07/2020
1	Valproic Acid (Depakote)FDA LinkGeneric 01/2020
1	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 12/2019
1	Biological FactorsIBA 01/2018
1	MB 5IBA 01/2018
1	MEK inhibitor IIBA 01/2018
1	Metformin (Glucophage)FDA LinkGeneric 01/2017

Therapy/Procedure

30	Drug Therapy (Chemotherapy) 05/2021 - 11/2006
21	Therapeutics 10/2022 - 09/2007
6	Radiotherapy 08/2022 - 05/2013
2	Terminal Care (Care, Terminal) 01/2021 - 01/2019
2	Investigational Therapies (Experimental Therapy) 01/2021 - 12/2020
2	Immunotherapy 01/2016 - 12/2015
1	Salvage Therapy 01/2022
1	Precision Medicine 01/2022
1	Hematopoietic Stem Cell Transplantation 11/2020
1	Cytoreduction Surgical Procedures 11/2020
1	Craniospinal Irradiation 01/2018
1	Palliative Care (Palliative Therapy) 01/2017